Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2008 Jun;19(2):139-44.
doi: 10.3802/jgo.2008.19.2.139. Epub 2008 Jun 20.

Tenascin-X and leukemia inhibitory factor receptor are down-regulated in leiomyoma compared with normal myometrium

Sun Ok Lee  1 , Soo Yoon Lee, Sa Ra Lee, Woong Ju, Seung Cheol Kim
Affiliations

Tenascin-X and leukemia inhibitory factor receptor are down-regulated in leiomyoma compared with normal myometrium

Sun Ok Lee et al. J Gynecol Oncol. 2008 Jun.

Abstract

Objective: Uterine leiomyomas are the most common tumor of the uterus. But the molecular causes of uterine leiomyoma remain unclear. We conducted the current investigation in order to elucidate the molecular mechanisms in the development of uterine leiomyoma.

Methods: We employed a new and accurate reverse transcription-polymerase chain reaction (RT-PCR) method that involved annealing control primers (ACPs) to identify the genes that are differently expressed in uterine leiomyoma.

Results: Using 120 ACPs, we identified and sequenced 14 differently expressed genes (DEGs) in uterine leiomyoma compared with normal myometrium. Basic Local Alignment Search Tool (BLAST) searches were performed to examine the known functions of these genes associated with uterine leiomyoma. We confirmed differently expressed patterns in more cases using the RT-PCR method. We also detected two novel genes, Tenascin-X and Leukemia Inhibitory Factor Receptor (LIFR), which had not yet been reported to have any functions associated with uterine leiomyoma. RT-PCR confirmation shows that both of these two genes are down-regulated in uterine leiomyoma.

Conclusion: Our results suggest that Tenascin-X and LIFR may play a role in the development of uterine leiomyoma. Although further studies are required to establish the precise mechanisms with which these genes are involved in the genesis of uterine leiomyoma, the present research is significant in that it is the first study which detects down-regulated novel genes in uterine leiomyoma using the ACP system.

Keywords: Annealing control primers (ACP) system; Leukemia inhibitory factor receptor (LIFR); Tenascin-X; Uterine leiomyoma.

PubMed Disclaimer

Figures

Fig. 1
Fig. 1
Common DEGs of leiomyoma and matched myometrium in initial two cases. lane 1; normal myometrium, lane 2; leiomyoma.
Fig. 2
Fig. 2
Sequencing and BLAST search.
Fig. 3
Fig. 3
Confirmation of DEGs by RT-PCR. N; normal myometrium, M; myoma.
Fig. 4
Fig. 4
Validation of DEGs by RT-PCR in another six more cases. N; normal myometrium, M; myoma.
Fig. 5
Fig. 5
Annealing control primer (ACP) structure. nts; nucleotides, PCR; polymerase chain reaction.
Fig. 6
Fig. 6
Structural models of the four tenascins.
Fig. 7
Fig. 7
Formation of the functional receptor complex for hOSM. hOSM; human oncostatin M, LIFR, leukemia inhibitory factor receptor, OSMR; oncostatin M receptor.
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

References

    1. Pokras R, Hufnagel VG. Hysterectomies in the United States 1965-84. Hyattsville, MD: US Department of Health and Human Services, Public Health Service, CDC; 1987. ((Vital and health statistics; series 13, no. 92)). DHHS publication no. (PHS) 88-1753. - PubMed
    1. Friedman AJ, Hoffman DI, Comite F, Browneller RW, Miller JD. Treatment of leiomyomata uteri with leuprolide acetate depot: A double-blind, placebo-controlled, multicenter study. The Leuprolide Study Group. Obstet Gynecol. 1991;77:720–725. - PubMed
    1. Brandon DD, Erickson TE, Keenan EJ, Strawn EY, Novy MJ, Burry KA, et al. Estrogen receptor gene expression in human uterine leiomyomata. J Clin Endocrinol Metab. 1995;80:1876–1881. - PubMed
    1. Yeh J, Rein M, Nowak R. Presence of messenger ribonucleic acid for epidermal growth factor (EGF) and EGF receptor demonstrable in monolayer cell cultures of myometria and leiomyomata. Fertil Steril. 1991;56:997–1000. - PubMed
    1. Pandis N, Heim S, Bardi G, Flodérus UM, Willén H, Mandahl N, et al. Chromosome analysis of 96 uterine leiomyomas. Cancer Genet Cytogenet. 1991;55:11–18. - PubMed